Eleven more lethal substances to be made Class A drugs, following a recommendation by the Advisory Council on the Misuse of Drugs (Home Office)
Bibliography: All Publications
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Hepatitis C in the UK 2023
Working to eliminate hepatitis C as a public health threat (Health Security Agency)
Substance misuse treatment for young people: statistics 2021 to 2022
Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)
Impact of the California Harm Reduction Initiative
RTI’s National Survey of Syringe Service Programs (SSPs) showed that California’s investment in harm reduction yielded high levels of life-saving interventions in its three years of existence
Naloxone knowledge among a sample of people that regularly consume illicit stimulants in Australia, 2022
This bulletin investigates naloxone knowledge among a sample of people that regularly use illicit stimulant drugs recruited from capital cities in Australia in 2022 (NDARC)
Preventing burnout and improving resilience in hospital-based addiction medicine professionals
This study asked 26 clinicians working on multidisciplinary addiction consultation teams to identify factors connected with burnout and resilience (Recovery Research Institute)
Rapid Action Drug Alerts and Response (RADAR) quarterly report
The Drugs Team at Public Health Scotland (PHS) has compiled this report of drug-related indicators in order to inform action to prevent drug harms and deaths
Opioids Prescribed to Adults at Discharge From Emergency Departments: United States, 2017–2020
Opioids may be an effective treatment for chronic and acute pain when properly used (1). However, receiving an opioid prescription in the emergency department (ED) has been identified as a potential risk factor for long-term use (CDCX)
Substance misuse treatment for adults: statistics 2021 to 2022
Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS)
Party Panel: developing theory- and evidence-based health promotion in nightlife settings
This paper describes the development and results of a web survey, named the Party Panel, that addresses emerging risks in nightlife settings (EMCDDA)
Drug Deaths Taskforce response: cross government approach
Cross government response to the Drug Deaths Taskforce report, Changing Lives. It contains a cross government action plan, response to Taskforce recommendations and a stigma action plan (Scottish Government)
High Intensity Drug Trafficking Areas Program 2022 Report to Congress
This document presents a national overview of the HIDTA Program, including an evaluation of each HIDTA, and addresses the following three Congressional reporting requirements in one cohesive and coordinated report (White House)
SAMHSA Announces National Survey on Drug Use and Health (NSDUH) Results Detailing Mental Illness and Substance Use Levels in 2021
The 2021 NSDUH national report includes selected estimates by race, ethnicity, and age group. It is the most comprehensive report on substance use and mental health indicators that SAMHSA has released to date
Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary (SAMHSA)
Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use
The Joint Committee on Justice has published its Report on an examination of the present approach to sanctions for possession of certain amounts of drugs for personal use in which it makes a series of recommendations on the issue (Houses of the Oireachtas, Ireland)
Deaths in prison
Examining causes, responses, and prevention of deaths in prison worldwide (Penal Reform International)
Quantitative and qualitative assessments of data quality within the European Web Survey on Drugs
This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EMCDDA)
Cannabis in Australia
More than a third of Australians aged over 14 have used cannabis at least once – 37%, or 7.6 million people. Around 2.4 million Australians used cannabis in 2019, as did 200 million people worldwide (Penington Institute)
Harm Reduction for People Who Use Drugs
Priorities for Investment and Increased Impact in HIV Programming (The Global Fund)
- 1
- 2
- 3
- …
- 96
- Next Page »
